3,061
Views
27
CrossRef citations to date
0
Altmetric
Research Article

A feasibility and safety study of computed tomography-guided percutaneous microwave ablation: a novel therapy for multiple synchronous ground-glass opacities of the lung

, , , , , , , , , , , & show all
Pages 414-422 | Received 16 Dec 2019, Accepted 07 Apr 2020, Published online: 29 Apr 2020

References

  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7–30.
  • Silva M, Pastorino U, Sverzellati N. Lung cancer screening with low-dose CT in Europe: strength and weakness of diverse independent screening trials. Clin Radiol. 2017;72:389–400.
  • Lee HY, Lee KS. Ground-glass opacity nodules: histopathology, imaging evaluation, and clinical implications. J Thorac Imaging. 2011;26:106–118.
  • Hansell DM, Bankier AA, MacMahon H, et al. Fleischner Society: glossary of terms for thoracic imaging. Radiology. 2008;246:697–722.
  • Lococo F, Cusumano G, De Filippis AF, et al. Current practices in the management of pulmonary ground-glass opacities: a survey of SICT Members. Ann Thorac Surg. 2018;106:1504–1511.
  • Kim HY, Shim YM, Lee KS, et al. Persistent pulmonary nodular ground-glass opacity at thin-section CT: histopathologic comparisons. Radiology. 2007;245:267–275.
  • Park CM, Goo JM, Lee HJ, et al. Nodular ground-glass opacity at thin-section CT: histologic correlation and evaluation of change at follow-up. Radiographics. 2007;27:391–408.
  • Travis WD, Brambilla E, Noguchi M, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011;6:244–285.
  • Migliore M, Fornito M, Palazzolo M, et al. Ground glass opacities management in the lung cancer screening era. Ann Transl Med. 2018;6:90–90.
  • MacMahon H, Naidich DP, Goo JM, et al. Guidelines for management of incidental pulmonary nodules detected on CT images: from the fleischner society 2017. Radiology. 2017;284:228–243.
  • Chen D, Dai C, Kadeer X, et al. New horizons in surgical treatment of ground-glass nodules of the lung: experience and controversies. TCRM. 2018;14:203–211.
  • Ye X, Fan W, Wang H, et al. Expert consensus workshop report: guidelines for thermal ablation of primary and metastatic lung tumors (2018 edition). J Can Res Ther. 2018;14:730–744.
  • Yang X, Ye X, Zheng A, et al. Percutaneous microwave ablation of stage I medically inoperable non-small cell lung cancer: clinical evaluation of 47 cases. J Surg Oncol. 2014;110:758–763.
  • Tafti BA, Genshaft S, Suh R, et al. Lung ablation: indications and techniques. Semin Intervent Radiol. 2019;36:163–175.
  • Liu J, Huang W, Wu Z, et al. The application of computed tomography-guided percutaneous coaxial biopsy combined with microwave ablation for pulmonary tumors. J Can Res Ther. 2019;15:760–765.
  • Wei Z, Wang Q, Ye X, et al. Microwave ablation followed by immediate biopsy in the treatment of non-small cell lung cancer. Int J Hyperthermia. 2018;35:262–268.
  • Solbiati LA. A valuable guideline for thermal ablation of primary and metastatic lung tumors. J Can Res Ther. 2018;14:725–726.
  • Hertzanu Y, Ye X. Computed tomography-guided percutaneous microwave ablation: a new weapon to treat ground-glass opacity-lung adenocarcinoma. J Cancer Res Ther. 2019;15:265–266.
  • Yang X, Ye X, Lin Z, et al. Computed tomography-guided percutaneous microwave ablation for treatment of peripheral ground-glass opacity-Lung adenocarcinoma: a pilot study. J Can Res Ther. 2018;14:764–771.
  • Matsuguma H, Yokoi K, Anraku M, et al. Proportion of ground-glass opacity on high-resolution computed tomography in clinical T1 N0 M0 adenocarcinoma of the lung: a predictor of lymph node metastasis. J Thorac Cardiovasc Surg. 2002;124:278–284.
  • Travis WD, Asamura H, Bankier AA, et al. The IASLC Lung Cancer Staging Project: Proposals for Coding T categories for subsolid nodules and assessment of tumor size in part-solid tumors in the forthcoming eighth edition of the TNM Classification of Lung Cancer. J Thorac Oncol. 2016;11:1204–1223.
  • Ahmed M, Solbiati L, Brace CL, et al.; For the International Working Group on Image-guided Tumor Ablation, Interventional Oncology Sans Frontières Expert Panel, Technology Assessment Committee of the Society of Interventional Radiology, and the Standard of Practice Committee of the Cardiovascular and Interventional Radiological Society of Europe. Image-guided tumor ablation: standardization of terminology and reporting criteria–a 10-year update. Radiology. 2014;273:241–260.
  • Cardella JF, Kundu S, Miller DL, et al.; Society of Interventional Radiology. Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol. 2009;20:S189–S191.
  • Sihoe ADL, Petersen RH, Cardillo G. Multiple pulmonary ground glass opacities: is it time for new guidelines? J Thorac Dis. 2018;10:5970–5973.
  • Kim TJ, Goo JM, Lee KW, et al. Clinical, pathological and thin-section CT features of persistent multiple ground-glass opacity nodules: comparison with solitary ground-glass opacity nodule. Lung Cancer. 2009;64:171–178.
  • Takamochi K, Oh S, Matsuoka J, et al. Clonality status of multifocal lung adenocarcinomas based on the mutation patterns of EGFR and K-ras. Lung Cancer. 2012;75:313–320.
  • Liu M, He WX, Song N, et al. Discrepancy of epidermal growth factor receptor mutation in lung adenocarcinoma presenting as multiple ground-glass opacities. Eur J Cardiothorac Surg. 2016;50:909–913.
  • Yu H, Zhang C, Liu S, et al. Application value of coaxial biopsy system in needle cutting biopsy for focal ground glass-like density nodule. J Can Res Ther. 2018;14:1509–1514.
  • Wang J, Ni Y, Yang X, et al. Diagnostic ability of percutaneous core biopsy immediately after microwave ablation for lung ground-glass opacity. J Can Res Ther. 2019;15:755–759.
  • Kodama H, Yamakado K, Hasegawa T, et al. Radiofrequency ablation for ground-glass opacity-dominant lung adenocarcinoma. J Vasc Interv Radiol. 2014;25:333–339.
  • Iguchi T, Hiraki T, Gobara H, et al. Percutaneous radiofrequency ablation of lung cancer presenting as ground-glass opacity. Cardiovasc Intervent Radiol. 2015;38:409–415.
  • Detterbeck FC, Homer RJ. Approach to the ground-glass nodule. Clin Chest Med. 2011;32:799–810.
  • Chen CK, Chou HP, Sheu MH. Image-guided lung tumor ablation: principle, technique, and current status. J Chin Med Assoc. 2013;76:303–311.
  • Welch BT, Brinjikji W, Schmit GD, et al. A national analysis of the complications, cost, and mortality of percutaneous lung ablation. J Vasc Interv Radiol. 2015;26:787–791.
  • Zheng A, Wang X, Yang X, et al. Major complications after lung microwave ablation: a single-center experience on 204 sessions. Ann Thorac Surg. 2014;98:243–248.
  • Huang G, Ye X, Yang X, et al. Invasive pulmonary aspergillosis secondary to microwave ablation: a multicenter retrospective study. Int J Hyperthermia. 2018;35:71–78.
  • Huang G, Liu Q, Ye X, et al. Invasive pulmonary aspergillosis: a rare complication after microwave ablation. Int J Hyperthermia. 2014;30:412–417.
  • Hiraki T, Gobara H, Mimura H, et al. Brachial nerve injury caused by percutaneous radiofrequency ablation of apical lung cancer: a report of four cases. J Vasc Interv Radiol. 2010;21:1129–1133.
  • Moon Y, Sung SW, Namkoong M, et al. The effectiveness of mediastinal lymph node evaluation in a patient with ground glass opacity tumor. J Thorac Dis. 2016;8:2617–2625.